238 related articles for article (PubMed ID: 22052309)
1. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis.
Parish LC; Parish JL; Routh HB; Fleischer AB; Avakian EV; Plaum S; Hardas B
J Drugs Dermatol; 2011 Nov; 10(11):1282-8. PubMed ID: 22052309
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris.
Parish LC; Parish JL; Routh HB; Avakian E; Olayinka B; Pappert EJ; Plaum S; Fleischer AB; Hardas B
J Drugs Dermatol; 2011 Oct; 10(10):1142-7. PubMed ID: 21968664
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
[TBL] [Abstract][Full Text] [Related]
4. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB
J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Naftifine HCl Cream 2% in the Treatment of Pediatric Subjects With Tinea Corporis.
Gold M; Dhawan S; Verma A; Kuligowski M; Dobrowski D
J Drugs Dermatol; 2016 Jun; 15(6):743-8. PubMed ID: 27272083
[TBL] [Abstract][Full Text] [Related]
6. An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea Pedis.
Verma A; Olayinka B; Fleischer AB
J Drugs Dermatol; 2015 Jul; 14(7):686-91. PubMed ID: 26151784
[TBL] [Abstract][Full Text] [Related]
7. Naftifine gel in the treatment of tinea pedis: two double-blind, multicenter studies. Naftifine Gel Study Group.
Cutis; 1991 Jul; 48(1):85-8. PubMed ID: 1868748
[TBL] [Abstract][Full Text] [Related]
8. Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. Naftifine Podiatric Study Group.
J Am Podiatr Med Assoc; 1990 Jun; 80(6):314-8. PubMed ID: 2189989
[TBL] [Abstract][Full Text] [Related]
9. The Role of Naftifine HCl 2% Gel and Cream in Treating Moccasin Tinea Pedis.
Vlahovic TC
J Drugs Dermatol; 2016 Feb; 15(2 Suppl):s56-9. PubMed ID: 26885800
[TBL] [Abstract][Full Text] [Related]
10. Econazole nitrate foam 1% for the treatment of tinea pedis: results from two double-blind, vehicle-controlled, phase 3 clinical trials.
Elewski BE; Vlahovic TC
J Drugs Dermatol; 2014 Jul; 13(7):803-8. PubMed ID: 25007362
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study.
Jarratt M; Jones T; Adelglass J; Bucko A; Pollak R; Roman-Miranda A; Olin JT; Swinyer L
J Drugs Dermatol; 2014 Jul; 13(7):838-46. PubMed ID: 25007368
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
[TBL] [Abstract][Full Text] [Related]
13. An open-label study of naftifine hydrochloride 1% gel in the treatment of tinea versicolor.
Gold MH; Bridges T; Avakian E; Plaum S; Pappert EJ; Fleischer AB; Hardas B
Skinmed; 2011; 9(5):283-6. PubMed ID: 22165042
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Naftifine Hydrochloride 2% Gel in Interdigital Tinea Pedis: A Phase III Randomised, Double-Blind, Parallel-Group, Active-Controlled Study in Indian Adult Patients.
Sinha SD; Rajamma A; Bandi MR; Sriramadasu SC; Sahu S; Kothiwala RK; Halder S; Sankerneni A; Panapakam M; Vemireddy VNR; Vattipalli R; Devireddy SR
Clin Drug Investig; 2023 Jul; 43(7):565-574. PubMed ID: 37462803
[TBL] [Abstract][Full Text] [Related]
15. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis].
Klaschka F; Gartmann H; Weidinger G
Z Hautkr; 1984 Sep; 59(18):1218-26. PubMed ID: 6388170
[TBL] [Abstract][Full Text] [Related]
16. Luliconazole for the treatment of interdigital tinea pedis: A double-blind, vehicle-controlled study.
Jarratt M; Jones T; Kempers S; Rich P; Morton K; Nakamura N; Tavakkol A
Cutis; 2013 Apr; 91(4):203-10. PubMed ID: 23763082
[TBL] [Abstract][Full Text] [Related]
17. Naftifine cream in the treatment of cutaneous candidiasis.
Zaias N; Astorga E; Cordero CN; Day RM; de Espinoza ZD; DeGryse R; Rojas RF; Sefton J
Cutis; 1988 Sep; 42(3):238-40. PubMed ID: 3048914
[TBL] [Abstract][Full Text] [Related]
18. Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis.
Millikan LE; Galen WK; Gewirtzman GB; Horwitz SN; Landow RK; Nesbitt LT; Roth HL; Sefton J; Day RM
J Am Acad Dermatol; 1988 Jan; 18(1 Pt 1):52-6. PubMed ID: 3279083
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of sertaconazole nitrate cream 2% for tinea pedis.
Savin R; Jorizzo J
Cutis; 2006 Oct; 78(4):268-74. PubMed ID: 17121064
[TBL] [Abstract][Full Text] [Related]
20. Ciclopirox gel in the treatment of patients with interdigital tinea pedis.
Aly R; Fisher G; Katz I; Levine N; Lookingbill DP; Lowe N; Menter A; Morman M; Pariser DM; Roth HL; Savin RC; Shavin JS; Stewart D; Taylor JR; Tucker S; Wortzman M
Int J Dermatol; 2003 Sep; 42 Suppl 1():29-35. PubMed ID: 14567368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
